tiprankstipranks
Trending News
More News >
Newron Pharmaceuticals SpA (CH:NWRN)
:NWRN

Compare Newron Pharmaceuticals SpA (NWRN) vs. Competitors

Compare
3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Newron Pharmaceuticals SpA
CHF19.76
CHF395.49M
16.50
108.88%
2 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.52
CHF141.92M
-2.17
-21.28%
0 Buy
1 Hold
0 Sell
Hold
Basilea Pharmaceutica
CHF56.50
CHF695.61M
9.45
40.72%
2 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.62
CHF929.20M
-5.41
409.87%
2 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF12.94
CHF180.10M
-2.52
-21.19%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF20.60
CHF121.12M
3.90
-0.47%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:NWRN
Newron Pharmaceuticals SpA
19.76
10.01
102.67%
CH:MOLN
Molecular Partners AG
3.52
-0.98
-21.80%
CH:BSLN
Basilea Pharmaceutica
56.50
15.85
38.99%
CH:IDIA
Idorsia Ltd
3.62
2.92
420.14%
CH:SANN
Santhera Pharmaceuticals Holding
12.94
-3.92
-23.25%
CH:XLS
Xlife Sciences Ltd.
21.00
-1.00
-4.55%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts